- Home
- APPS vs SVRA Comparison
APPS vs SVRA Comparison
Compare APPS & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APPS | SVRA |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2012 | 2009 |
Fundamental Metrics
Financial Performance| Metric | APPS | SVRA |
|---|---|---|
| Price | $7.12 | $4.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $17.00 | $11.06 |
| AVG Volume (30 Days) | ★ 2.7M | 2.4M |
| Earning Date | 11-09-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.92 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $103,569,000.00 | N/A |
| Revenue This Year | $18.67 | N/A |
| Revenue Next Year | $11.41 | $4,336.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 38.55 | N/A |
| 52 Week Low | $2.74 | $4.03 |
| 52 Week High | $15.34 | $7.01 |
Technical Indicators
Market Signals| Indicator | APPS | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 36.31 | 52.37 |
| Support Level | $3.36 | $4.73 |
| Resistance Level | $11.78 | $5.47 |
| Average True Range (ATR) | 0.90 | 0.32 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 4.26 | 77.49 |
Price Performance
Historical ComparisonAbout APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform that levels up the landscape for advertisers, publishers, carriers, and device original equipment manufacturers. The Company offers end-to-end products and solutions leveraging proprietary technology to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. In addition, its products and solutions provide monetization opportunities for OEMs, carriers, and application (app or apps) publishers and developers.
About SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).